Accrelist Ltd. (SGX:QZG)
Singapore · Delayed Price · Currency is SGD 0.0550
+0.0010 (1.85%)
At close: Jun 11, 2026
Accrelist Income Statement
Financials in millions SGD. Fiscal year is April - March.
Millions SGD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 15.64 | 14.03 | 13.36 | 19.13 | 40.59 | |
Revenue Growth (YoY) | 11.48% | 5.01% | -30.15% | -52.88% | -73.17% |
Cost of Revenue | 8.34 | 8.69 | 9.03 | 13.72 | 33.9 |
Gross Profit | 7.3 | 5.34 | 4.33 | 5.4 | 6.69 |
Selling, General & Admin | 10.1 | 11.12 | 10.06 | 9.8 | 11.08 |
Operating Expenses | 10.1 | 13.63 | 10.44 | 10.43 | 11.75 |
Operating Income | -2.79 | -8.28 | -6.11 | -5.03 | -5.06 |
Interest Expense | -0.14 | -0.18 | -0.23 | -0.29 | -0.26 |
Interest & Investment Income | 0.11 | 0.09 | 0.3 | 0.05 | 0.03 |
Earnings From Equity Investments | 0.85 | 0.31 | -0.24 | - | - |
Currency Exchange Gain (Loss) | 0.09 | 0.3 | -0.56 | 0.14 | 0.1 |
Other Non Operating Income (Expenses) | 0.49 | -0.23 | 0.62 | 0.7 | 0.36 |
EBT Excluding Unusual Items | -1.39 | -7.99 | -6.22 | -4.43 | -4.82 |
Impairment of Goodwill | - | - | -0.16 | - | -3.95 |
Gain (Loss) on Sale of Investments | - | 0.11 | 0.01 | 2.22 | -2.19 |
Gain (Loss) on Sale of Assets | - | - | - | 0.06 | 0.01 |
Asset Writedown | - | - | - | -0.02 | -0.03 |
Pretax Income | -1.39 | -7.88 | -6.37 | -2.18 | -10.98 |
Income Tax Expense | - | 0.03 | 0.03 | -0.05 | 0.23 |
Earnings From Continuing Operations | -1.39 | -7.91 | -6.4 | -2.13 | -11.21 |
Earnings From Discontinued Operations | - | -0.15 | 4.52 | -7.92 | -3.25 |
Net Income to Company | -1.39 | -8.06 | -1.88 | -10.05 | -14.46 |
Minority Interest in Earnings | 1.12 | 3.4 | -0.44 | 4.65 | 2.64 |
Net Income | -0.26 | -4.66 | -2.32 | -5.4 | -11.81 |
Net Income to Common | -0.26 | -4.66 | -2.32 | -5.4 | -11.81 |
Shares Outstanding (Basic) | - | 317 | 309 | 304 | 293 |
Shares Outstanding (Diluted) | - | 317 | 309 | 304 | 293 |
Shares Change (YoY) | - | 2.31% | 1.86% | 3.51% | 5.12% |
EPS (Basic) | - | -0.01 | -0.01 | -0.02 | -0.04 |
EPS (Diluted) | - | -0.01 | -0.01 | -0.02 | -0.04 |
Free Cash Flow | 0.31 | -3.18 | -8.27 | 0.43 | -2.1 |
Free Cash Flow Per Share | - | -0.01 | -0.03 | 0.00 | -0.01 |
Gross Margin | 46.70% | 38.09% | 32.43% | 28.25% | 16.49% |
Operating Margin | -17.84% | -59.02% | -45.71% | -26.28% | -12.46% |
Profit Margin | -1.69% | -33.23% | -17.39% | -28.23% | -29.10% |
Free Cash Flow Margin | 1.96% | -22.64% | -61.89% | 2.24% | -5.18% |
EBITDA | -0.23 | -5.49 | -3.05 | -1 | -0.5 |
EBITDA Margin | -1.50% | -39.09% | -22.84% | -5.25% | -1.23% |
D&A For EBITDA | 2.56 | 2.8 | 3.06 | 4.02 | 4.56 |
EBIT | -2.79 | -8.28 | -6.11 | -5.03 | -5.06 |
EBIT Margin | -17.84% | -59.02% | -45.71% | -26.28% | -12.46% |